Clinical Trial Update: Clinical Trial Comparing Safety and Pharmacokinetics of Standard Antibiotic Therapy, Plus Aurexis® or Placebo, for Treatment of Staphylococcus Aureus Bacteremia (SAB) [Phase 2]

View source ↗

Summary

A completed Phase 2 trial compared safety and pharmacokinetics of standard antibiotic therapy plus Aurexis versus placebo in Staphylococcus aureus bacteremia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcus Aureus Bacteremia

Drugs mentioned

• Aurexis

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Staphylococcus Aureus Bacteremia | Phase 2 | Status: COMPLETED